Byllye Avery, cofounder of the Black Women’s Health Imperative, speaks to historian Susan Reverby about her activist work, beginning in the 1970s, to increase women’s access to abortion. She discusses the state of reproductive rights before and after Roe v. Wade, the genesis of the “reproductive justice” movement, and the tactics that might be needed in a post-Roe future.
Carrie Baker, Alexandra Brodsky, Tara Conley, and Judith Levine discuss Linda Hirshman’s Reckoning: The Epic Battle against Sexual Abuse and Harassment, with a response from Hirshman.
Sarah Deer, Melissa Jeltsen, Qudsia Raja, and Natalie J. Sokoloff discuss Rachel Louise Snyder’s No Visible Bruises, with a response from Snyder.
How has feminism shaped US asylum law? Why and how is the Trump Administration trying to undo feminist gains? Hear asylum- and refugee-law expert Deborah Anker discuss the history and present of gender in the US asylum system in the latest episode of Ask a Feminist.
Sheila Bapat, Grace Chang, Leigh Gilmore, Evelyn Nakano Glenn, and Emily J. Martin discuss Stephanie Land’s Maid, with a response from the author.
Feminist journalist, media critic, and activist Soraya Chemaly joins Carla Kaplan and Durba Mitra for an in-depth discussion of feminist rage. Their wide-ranging conversation covers many aspects of contemporary women’s rage: the Kavanaugh Supreme Court confirmation process, the furor over Serena Williams’s US Open final, and how to differentiate progressive anger from the reactionary anger that has fueled the Right, including the rise of Trump.
Soraya Chemaly sits down with Carla Kaplan and Durba Mitra to discuss the uses of rage in catalyzing political change, how to differentiate progressive anger from reactionary anger, and more.
Moya Bailey and Kai Green discuss Charlene A. Carruthers’s book Unapologetic: A Black, Queer, and Feminist Mandate for Radical Movements, with a response from Carruthers.
Shoshanna Ehrlich, Holloway Sparks, Jamia Wilson, and Andi Zeisler discuss Soraya Chemaly’s Rage Becomes Her, with a response from Chemaly.
